Milciclib (PHA-848125)

99%

  • Product Code: 101407
  CAS:    802539-81-7
Molecular Weight: 460.57 g./mol Molecular Formula: C₂₅H₃₂N₈O
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20℃
Product Description: Milciclib is primarily investigated for its potential in treating various types of cancer. It functions as a cyclin-dependent kinase (CDK) inhibitor, targeting specific enzymes involved in cell cycle regulation. By inhibiting these enzymes, it disrupts the proliferation of cancer cells, making it a candidate for therapeutic use in malignancies such as thymic carcinoma and other solid tumors. Clinical trials have explored its efficacy and safety, particularly in patients who have not responded to standard treatments. Additionally, its role in combination therapies is being studied to enhance its anticancer effects and improve patient outcomes.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days ฿4,473.00
+
-
Milciclib (PHA-848125)
Milciclib is primarily investigated for its potential in treating various types of cancer. It functions as a cyclin-dependent kinase (CDK) inhibitor, targeting specific enzymes involved in cell cycle regulation. By inhibiting these enzymes, it disrupts the proliferation of cancer cells, making it a candidate for therapeutic use in malignancies such as thymic carcinoma and other solid tumors. Clinical trials have explored its efficacy and safety, particularly in patients who have not responded to standard treatments. Additionally, its role in combination therapies is being studied to enhance its anticancer effects and improve patient outcomes.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :